Company: GEHC
Filing Date: 2025-10-29
Form Type: 10-Q
Source: 0001932393-25-000053
Chunk: 77

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-10-29
Form: 10-Q
Item: Item 8
Chunk 77
---
, 2024Loans receivable, at amortized cost$18 $23 Investment in finance leases, net of deferred income77 69 Allowance for credit losses(1)(2)Current financing receivables – net$94 $90 Loans receivable, at amortized cost$44 $35 Investment in finance leases, net of deferred income153 152 Allowance for credit losses(3)(4)Non-current financing receivables – net$194 $183 As of September 30, 2025, 2%, 1%, and 1% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral. As of December 31, 2024, 4%, 4%, and 3% of financing receivables were over 30 days past due, over 90 days past due, and on nonaccrual, respectively, with the majority of nonaccrual financing receivables secured by collateral.

NOTE 6. LEASES

Operating lease liabilities recognized within All other current liabilities and All other non-current liabilities in the Condensed Consolidated Statements of Financial Position were $419 million and $385 million as of September 30, 2025 and December 31, 2024, respectively. The total lease expense related to our operating lease portfolio was $63 million and $70 million for the three months ended September 30, 2025 and 2024, respectively, and $185 million and $189 million for the nine months ended September 30, 2025 and 2024, respectively.

14

NOTE 7. ACQUISITIONS, GOODWILL, AND OTHER INTANGIBLE ASSETS

PROPOSED ACQUISITION.On September 10, 2025, we announced an agreement to acquire icometrix NV, a Belgium based company. The anticipated acquisition aligns with our precision care strategy with a goal of strengthening our portfolio of offerings in neurological care. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including regulatory approval.ACQUISITIONS.Nihon Medi-PhysicsOn March 31, 2025, the Company acquired the remaining 50% interest in Nihon Medi-Physics Co., Ltd. (“